Updates from The Motley Fool

Latest updates on Codexis from Fool.com.


Stock Performance

CDXS vs. S&P 500 | 2 Year Performance
CDXS 1-Day Stock Chart
CDXS 5-Day Stock Chart
CDXS 1-Month Stock Chart
CDXS 3-Month Stock Chart
CDXS 6-Month Stock Chart
CDXS 1-Year Stock Chart
CDXS 2-Year Stock Chart
CDXS 5-Year Stock Chart
View Interactive CDXS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Codexis .
Current Price: $3.80
Prev Close: $3.73
Open: $3.73
Bid: $3.80
Ask: $3.81
Day's Range: $3.68 - $3.84
52wk Range: $2.93 - $4.72
Volume: 41,126
Avg Vol 69,791
Market Cap: $153.17M
P/E (ttm): 23.31
EPS (ttm): $0.16
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Codexis .
CAPS Rating 2 out of 5
 
42 Outperform
7 Underperform
CAPS All Stars
 
8 Outperform
3 Underperform

How do you think Codexis will perform against the market?



You pick for Codexis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John J. Nicols, CEO

48% Approve

Based on 19 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Codexis .

Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers